Home » Newsletters » BioWorld Science

BioWorld Science

March 26, 2015

View Archived Issues

Preclinical results presented for a BAX activator molecule

Sunitinib shows antitumor activity in thyroid cancer patients

Prozymex reports development of DPP-I inhibitors

University of Texas System patent describes new engineered primate L-methioninase

Peloton Therapeutics presents HIF-2alpha inhibitors

Dako and Amgen expand companion diagnostics collaboration

Scientists design novel PHEO mouse model

Imaging agent 64Cu-DOTA-AE-105 tested in prostate cancer patients

Further clinical data reported for preregistered hypercholesterolemia treatment evolocumab

La Jolla initiates phase III trial of LJPC-501 for catecholamine-resistant hypotension

ThromboGenics reports topline data on Jetrea in symptomatic vitreomacular adhesion

Nippon Shinyaku to continue clinical development of NS-065 for DMD

GenVec and TheraBiologics to develop cancer therapies based on neural stem cell technology

New S1P1 antagonist presented for the treatment of autoimmune disease

Gilead's sofosbuvir approved in Japan for genotype 2 HCV infection

Regulus receives European orphan medicinal product designation for RG-012

FDA approves Regeneron's aflibercept for diabetic retinopathy in diabetic macular edema

Quadracel approved in U.S. for vaccination of children aged 4-6 years

EUSA Pharma regains independence from Jazz Pharmaceuticals

Università degli Studi di Padova describes use of SERPINB3 for SLE

Therapure Innovations receives FDA approval to conduct phase I trial of TBI-302

Calitor Sciences discloses ALK and/or HGFR inhibitors

Sun Pharmaceutical completes acquisition of Ranbaxy from Daiichi Sankyo

FDA approves Emergent BioSolutions' Anthrasil for treatment of inhalational anthrax

MBX-8025 gains U.S. orphan drug status for homozygous familial hypercholesterolemia

Lilly's Cyramza obtains approval for gastric cancer in Japan

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Dec. 31, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Jan. 2, 2026.
AND-017 increases RBC and hemoglobin in sickle cell disease
BioWorld Science
Sickle cell disease (SCD) is an inherited hemoglobinopathy caused by a mutation in the gene encoding β-globin that results in hemoglobin S polymerization, red...
Shionogi nabs revenue-generating ALS drugs with $2.5B Tanabe pact
BioWorld
Shionogi & Co. Ltd. will acquire global rights to U.S. FDA approved amyotrophic lateral sclerosis therapy edaravone through a $2.5 billion acquisition deal with...
Big pharma taps fast Asia innovation in search of next Keytruda
BioWorld
Speed and innovation from Asia Pacific’s (APAC) biotechnology sector had big pharma scouring the region for the next oncology heir to Keytruda (pembrolizumab),...